Update
Only logged in members can reply and interact with the post.
Join SimilarWorlds for FREE »

Trump Revokes Biden's Order to Lower Drug Prices for Medicare

By Kiplinger News Letter

Trump Revokes Biden's Order to Lower Drug Prices for Medicare

Biden's Executive Order to lower copays for some drugs to $2 for Medicare and Medicaid enrollees is nixed by President Trump.

Known as Executive Order 14087, it was designed to identify a list of prescription drugs that would, under the plan, require only a $2 copay a month for anyone on Medicare. Former President Biden had directed the Center for Medicare and Medicaid Innovation, an arm of the Centers for Medicare and Medicaid Services, to look into ways to make prescription drugs cheaper for Medicare recipients.

“Too many Americans face challenges paying for prescription drugs. On average, Americans pay two to three times as much as people in other countries for prescription drugs, and one in four Americans who take prescription drugs struggle to afford their medications,” Biden said at the time. “Nearly 3 in 10 American adults who take prescription drugs say that they have skipped doses, cut pills in half, or not filled prescriptions due to cost.”
This page is a permanent link to the reply below and its nested replies. See all post replies »
Prison1203 · 61-69, M
While Trump's reversal of Biden's order did not immediately change any existing laws and regulations on prescription drug pricing for Medicare and Medicaid, it did create uncertainty about the federal government's approach to addressing prescription drug costs.

Dr. Mark McClellan, director of the Margolis Institute for Health Policy at Duke University and CMS administrator during the George W. Bush administration, told Newsweek that "just because [Biden's executive order] was withdrawn does not necessarily mean that the payment reform pilots that are in process (on $2 generic drugs or [Sickle Cell Disease] gene therapy access) will be."

"They could be withdrawn, but the new administration could also choose to continue or to build on these specific programs," McClellan added. "I havent seen any statements on that yet."